Synthetic MMP inhibitors could suppress lipid accumulation in human mesenchymal stem cells and adipogenesis (Bosco et al., 2017), suggesting a possible protective function of MT1-MMP in the development of obesity. The gene discussed is MMP14; the disease is obesity due to melanocortin 4 receptor deficiency.